Stockreport

Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
PDF RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular marker [Read more]